75 / 160
627
53. Mooney P, Hadjivassiliou M, Sanders D. Emerging drugs for coeliac
disease. Expert Opin Emerging Drugs 2014; 19: 533-544.
54. Murray J, Watson T, Clearman B, Mitros F. Effect of a gluten-free
diet on gastrointestinal symptoms in celiac disease. Am J Nutr
2004; 79: 669-673.
55. Zanini B, Lanzarotto F, Mora A, et al. Five year time course of celiac
disease serology during gluten free diet: results of a community
based “CD-Watch” program. Dig Liver Dis 2010; 42: 865-870.
56. Lebwohl B, Granath F, Ekbom A, et al. Mucosal healing and
mortality in coeliac disease. Aliment Pharmacol Ther 2013; 373:
332-339.
57. Leffler D, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly CP.
Etiologies and predictors of diagnosis in nonresponsive celiac
disease. Clin Gastroenterol Hepatol 2007; 5: 445-450.
58. Malamut G, Afchain P, Verkarre V, et al. Presentation and Long-
Term Follow-up of Refractory Celiac Disease: Comparison of Type
I With Type II. Gastroenterology 2009; 136: 81-90.
59. West J, Logan R, Smith C, Hubbard R, Card T. Malignancy and
mortality in people with coeliac disease: population based
cohort study. BMJ 2004; 329: 716-719.
60. Pereyra L, Gonzalez R, Mohaidle A, et al. Risk of colorectal
neoplasia in patients with celiac disease: a multicenter study. J
Crohns Colitis 2013; 7: 672-677..
61. Catassi C, Bearzi I, Holmes G. Association of Celiac Disease and
Intestinal Lymphomas and Other Cancers. Gastroenterology
2005; 128: S79-S86.
62. Kelly C, Bai J, Liu E, Leffler D. Advances in Diagnosis and
Management of Celiac Disease. Gastroenterology 2015; 148:
1175-1186.
[enfermedad celiaca: revisión - Dr. Felipe Moscoso J. y col.]